20-45377540-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_014477.3(TP53TG5):c.122C>T(p.Thr41Met) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000315 in 1,461,692 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_014477.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TP53TG5 | NM_014477.3 | c.122C>T | p.Thr41Met | missense_variant, splice_region_variant | 2/5 | ENST00000372726.5 | NP_055292.1 | |
TP53TG5 | XM_011528790.3 | c.74C>T | p.Thr25Met | missense_variant, splice_region_variant | 2/5 | XP_011527092.1 | ||
SYS1-DBNDD2 | NR_003189.2 | n.380+11854G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TP53TG5 | ENST00000372726.5 | c.122C>T | p.Thr41Met | missense_variant, splice_region_variant | 2/5 | 1 | NM_014477.3 | ENSP00000361811.3 | ||
SYS1-DBNDD2 | ENST00000458187.5 | n.230+11854G>A | intron_variant | 5 | ENSP00000457768.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251060Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135710
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461692Hom.: 0 Cov.: 32 AF XY: 0.0000413 AC XY: 30AN XY: 727132
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 26, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at